Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
2020 Life Science Innovation Northwest - Schedule
Share |

Explore your options to connect, learn, and be inspired at the 2020 Life Science Innovation Conference. New panelists and speakers are being added often… check back for updates. The schedule is subject to change.





CONFERENCE HIGHLIGHTS

DAY 1: THURSDAY JULY 16, 2020

7:30 AM - REGISTRATION AND NETWORKING

8:00 AM - WELCOME

Leslie Alexandre, DrPH, CEO & President, Life Science Washington

8:10 AM - KEYNOTE ADDRESS: WHAT WILL IT TAKE TO FURTHER REDUCE DEATH FROM CANCER IN 2030?

Life Science Innovation Northwest - Keynote Speaker - Thomas Lynch Jr, MD, President & Director, Fred Hutch

Thomas Lynch Jr, MD

President & Director, Fred Hutch


This presentation will look at recent progress in cancer mortality using lung cancer as an example and will examine the factors driving the progress to date. Dr. Lynch will also focus on progress in precision medicine, immune-oncology, cell therapy, enhanced screening, and early detection that will be needed to make even more progress by 2030.

9:00 AM

PANELIST/SPEAKER

SURVIVING AND THRIVING WITH CANCER IN 2030: THE ROLE OF ADVANCED DIAGNOSTICS AND PROGNOSTICS

Achieving Dr. Lynch’s powerful vision for cancer prevention and treatment in 2030 will require molecular testing at a scale not yet seen. Testing for inherited predisposition to many more cancers than currently possible. Testing to more accurately and specifically diagnose and treat an individual’s “cancer” based on their molecular profile and that of their tumor. Testing to guide future treatment based on metastases and minimal residual disease.

This panel will dive deeply into the state of cancer-related molecular testing today and what is on the horizon. How far have we come in the past 10 years and how far do we have to go to meet Dr. Lynch’s vision? 

Moderator: Kim Popovits, Former Chairman of the Board, Chief Executive Officer and President, Genomic Health

Bonnie H. Anderson, Chairman of the Board and Chief Executive Officer, Veracyte

Chad Robins, MBA, Chief Executive Officer and Co-founder, Adaptive Biotechnologies

Sarah Warren, PhD, Senior Director of Translational Science, nanoString Technologies

10:00 AM - BREAK

10:15 AM

 

 

COMPANY PODIUM PRESENTATIONS

Podium Presentations are the perfect way to increase visibility for your company and attract strategic partners at LSINW. Pitch your company’s story, pipelines, and objectives!  


Individual Company Presentations

12:20 PM

 

ADDRESS BY US CONGRESSWOMAN SUZAN DELBENE

United States Congresswomen Suzan DelBene will discuss Federal policy that impacts both biotech and medical device companies.  Rep. DelBene started her career in biotech research.  Today, she serves on the powerful Ways & Means committee, which has jurisdiction over Federal tax and revenue policy as well as Medicare.  She will discuss ideas for modernizing CMS to ensure that innovation can flourish  and as well as her work to repeal the Medical Device Tax, provide accelerated coverage for FDA-designated breakthrough products, and discuss medical supply chain issues.

 

U.S. Congresswoman Suzan DelBene, MBA, Washington’s First Congressional District

2:00 PM - BREAK

2:15 PM

 

 

COMPANY PODIUM PRESENTATIONS

Podium Presentations are the perfect way to increase visibility for your company and attract strategic partners at LSINW. Pitch your company’s story, pipelines, and objectives!  


Individual Company Presentations

3:30 PM

PANELIST/SPEAKER

PANEL: KEEPING MEDICAL DEVICE INNOVATION FUNDING ALIVE AND WELL

Where do investors and acquirers see continued opportunities in medical devices? The panel of experts will discuss this question, as well as reimbursement headwinds, and what is being done at the American Medical Association to promote innovation in Current Procedural Terminology medical coding.

Moderator: Wende Hutton, MBA, General Partner for West Coast, Canaan

Laurie McGraw, Senior Vice President, Health Solutions AMA

Trevor Moody, MScM, Partner, Medical Devices, M.H. Carnegie & Co.

Neil Oberoi, MBA, Senior Managing Director, Guggenheim Securities

Brad Vale, PhD, Founder and General Partner, Strategic Healthcare Investment Partners

4:30 PM - BREAK

4:45 PM

JUDGE

FAST PITCH COMPETITION

Carla Fowler, MD, PhD, Managing Director, THAXA, Inc.

Scott Maloney, Founder, Crain & Company

Jim Reed, Managing Partner, Reed Global Advisors, LLC

Richard Samuelson, CFA, Partner, Swan Venture Group

6:00 PM - END OF DAY 1


DAY 2: FRIDAY, JULY 17, 2020

7:30 AM - REGISTRATION AND NETWORKING

8:00 AM - WELCOME:

Margaret McCormick, PhD, Executive Director, Benaroya Research Institute at Virginia Mason
Board Chair, Life Science Washington

8:05 AM - KEYNOTE ADDRESS: EMBRACING AI AS A TOOL FOR DRUG DISCOVERY

Life Science Innovation Northwest - Keynote Speaker - Kim Branson, PhD Senior VP and Global Head of AI/ML, GlaxoSmithKline

Kim Branson, PhD

Senior VP and Global Head of AI/ML, GlaxoSmithKline


Artificial intelligence can play a wide range across the pharmaceutical discovery and development process. Hear how GSK is using AI to identify novel drug targets, design new molecules and vaccines and its role in clinical development.

9:00 AM

 

PANEL: AI-DRIVEN DRUG DISCOVERY AND DEVELOPMENT

AI and machine learning have only started to scratch the surface of what they can deliver for drug development, promising radical changes in not only efficiency, but the scope of therapeutics and diagnostics that could be created. But alongside the actual potential is a huge amount of hype. The panel will deconstruct where AI and machine learning can deliver, and on what timeframe, and how the industry should take responsibility for managing expectations and raising the conversation above the hype.


Panel Chair: Simone Fishburn, PhD, VP and Editor in Chief, BioCentury Inc.

Jeff Elton, PhD, CEO, ConcertAI

Lara Mangravite, PhD, President, Sage Bionetworks

Julie Sunderland, MBA, Managing Director, Biomatics Capital

10:00 AM - BREAK

10:15 AM

 

COMPANY PODIUM PRESENTATIONS

Podium Presentations are the perfect way to increase visibility for your company and attract strategic partners at LSINW. Pitch your company’s story, pipelines, and objectives!  


Individual Company Presentations

12:30 PM

PANELIST/SPEAKER

THE STATE OF VACCINES AND THERAPEUTIC NEUTRALIZING ANTIBODIES FOR COVID-19

The ultimate victory against COVID-19 will have to come through active immunization campaigns with a vaccine. But there are also passive immunization strategies in the works with therapeutic neutralizing antibodies, which could make a big difference months before a vaccine arrives. Hear from vaccine expert Larry Corey of Fred Hutch, and David Weinreich, SVP of global clinical development at Regeneron, about the latest in active and passive immunization strategies against the virus.

Moderator: Luke Timmerman, Journalist, Timmerman Report

Larry Corey, MD, President and Director Emeritus, Fred Hutch

David Weinreich, MD, MBA, Senior Vice President, Global Clinical Development, Regeneron Pharmaceuticals, Inc.

1:30 PM

PANELIST/SPEAKER

FIRESIDE CHAT: IMPACT OF COVID 19 ON THE FINANCIAL MARKETS/INVESTMENT ENVIRONMENT

Join a conversation with a seasoned life sciences investor as we discuss the pandemic’s effect on the life sciences financial market. Gain insight on how to navigate biotech and life science investing and where things will go from here.

Robert Nelsen, MBA, Co-founder & Managing Director, Arch Venture Partners

Luke Timmerman, Journalist, Timmerman Report

2:30 PM - PROGRAM CONCLUSION



more Calendar

The upcoming calendar is currently empty.

Click here to view past events and photos »

Featured Member
Biotech Primer Inc.Biotech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal